KLSE (MYR): CENGILD (0243)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
0.47
Today's Change
0.00 (0.00%)
Day's Change
0.46 - 0.48
Trading Volume
1,893,000
Market Cap
385 Million
NOSH
600 Million
Avg Volume (4 weeks)
4,031,700
4 Weeks Range
0.375 - 0.485
4 Weeks Price Volatility (%)
52 Weeks Range
0.335 - 0.52
52 Weeks Price Volatility (%)
Previous Close
0.47
Open
0.47
Bid
0.47 x 117,500
Ask
0.475 x 343,500
Day's Range
0.46 - 0.48
Trading Volume
1,893,000
Latest Quarter | Ann. Date
31-Mar-2022 [#3] | 26-May-2022
Next QR | Est. Ann. Date
30-Jun-2022 | 26-Aug-2022
T4Q P/E | EY
28.27 | 3.54%
T4Q DY | Payout %
0.00% | 0.00%
T4Q NAPS | P/NAPS
0.03 | 14.55
T4Q NP Margin | ROE
15.51% | 51.48%
Sector: HEALTH CARE
Sector: HEALTH CARE
Subsector: HEALTH CARE PROVIDERS
Subsector: HEALTH CARE PROVIDERS
Description:
Cengild Medical Berhad is a Malaysia-based investment holding company. The Company through its subsidiary, is a healthcare provider specializing in the diagnosis and treatment of gastrointestinal and liver disease. Its medical center's business activities comprise of consultant services and medical management services, which includes nursing services and clinical support services. Its medical center facilities offers 10 clinics, three endoscopy rooms, 28 beds (which include eight-day care beds), special diagnostic (treadmill stress test and echocardiography) department, two operating theatres, radiology department, accident and emergency department, pharmacy, laboratory, and central sterile supply department. In addition, it also offers 24-hour outpatient accident and emergency service, health screening, physiotherapy and histopathology services. Its imaging facilities includes fibro scan, ultrasonography, CT scan, fluoroscopy, and angiography equipment.
Besides the main 6 consultants, Cengild also have :
Visiting consultants=17
One of the 6 consultants, Dato' Dr Tan Huck Joo is also a visiting consultant for Sunway Medical Centre, C-G-3, Ground Floor, Tower C, +603-7491 9191 (Ext. 20527)
Thus, the visiting consultants can cover the operations even if 1-2 of the main consultants decided to leave. Of course, leaving without their ESOS.
2022-04-19 11:15
Both new April IPO listing PPJACK and CENGILD are star performers of the month .
Stay tuned.
2022-04-19 15:29
Cengild poised for further robust growth post IPO.
-------------------------------------------------
Cengild raised RM72 million from its IPO with 218.8 million new shares.
Of the proceeds, it intends to use RM37.1 million to establish new medical centres, RM17.4 million for working capital, RM13 million for expansion of existing medical centres and the remaining RM4.7 million for listing expenses.
The group plans to expand its existing medical centre at Nexus @ Bangsar South, Kuala Lumpur, by leasing additional space of approximately 12,000 to 15,000 square feet to cater to current and future demand for its medical services, especially endoscopic procedures to strengthen its position in the segment.
It also intends to expand its presence by establishing two new full-fledged medical centres specialising in gastrointestinal and liver diseases, and obesity in other major cities in Malaysia such as Johor Bahru, Penang or Ipoh.
In order to support the expansion of its existing medical centre as well as into other major cities in Malaysia, it also intends to strengthen its medical team by attracting and recruiting consultants specialising in gastroenterology and hepatology.
2022-04-20 02:38
Cengild poised for further robust growth post IPO.
-------------------------------------------------
Cengild raised RM72 million from its IPO with 218.8 million new shares.
Of the proceeds, it intends to use RM37.1 million to establish new medical centres, RM17.4 million for working capital, RM13 million for expansion of existing medical centres and the remaining RM4.7 million for listing expenses.
The group plans to expand its existing medical centre at Nexus @ Bangsar South, Kuala Lumpur, by leasing additional space of approximately 12,000 to 15,000 square feet to cater to current and future demand for its medical services, especially endoscopic procedures to strengthen its position in the segment.
It also intends to expand its presence by establishing two new full-fledged medical centres specialising in gastrointestinal and liver diseases, and obesity in other major cities in Malaysia such as Johor Bahru, Penang or Ipoh.
In order to support the expansion of its existing medical centre as well as into other major cities in Malaysia, it also intends to strengthen its medical team by attracting and recruiting consultants specialising in gastroenterology and hepatology.
2022-04-20 14:14
Cengild poised for further robust growth post IPO.
-------------------------------------------------
Cengild raised RM72 million from its IPO with 218.8 million new shares.
Of the proceeds, it intends to use RM37.1 million to establish new medical centres, RM17.4 million for working capital, RM13 million for expansion of existing medical centres and the remaining RM4.7 million for listing expenses.
The group plans to expand its existing medical centre at Nexus @ Bangsar South, Kuala Lumpur, by leasing additional space of approximately 12,000 to 15,000 square feet to cater to current and future demand for its medical services, especially endoscopic procedures to strengthen its position in the segment.
It also intends to expand its presence by establishing two new full-fledged medical centres specialising in gastrointestinal and liver diseases, and obesity in other major cities in Malaysia such as Johor Bahru, Penang or Ipoh.
In order to support the expansion of its existing medical centre as well as into other major cities in Malaysia, it also intends to strengthen its medical team by attracting and recruiting consultants specialising in gastroenterology and hepatology.
2022-04-22 13:44
This is a very good stock for an investor.. healthy cashflow, borrowing, and growing profit..
2022-05-06 19:20
Waiting for one more round of lowest support line......then move in.....not too early, not to late.....this isn't gonna fly anytime yet.
2022-05-12 13:25
Last support at 425c........if higher support line.....Go, Go, Go....
2022-05-12 13:26
Wah, if drop that much, will continue inject more money for sure. But share price too low, a bit sad.
2 months ago
RTA09391
Market cap too huge,
2022-04-19 09:05